Science Daily

HIV/AIDS: Promising results from infant treatment with protease inhibitor lopinavir LPV/r, study suggests

A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning "the whole treatment world on its head," according to pediatrician researchers. New treatment with LPV/r ...
Aidsmap

Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Monthly Prescribing Reference

Risk of Adverse Birth Outcomes No Higher With TDF-FTC-LPV/r

The researchers compared the risks of adverse birth outcomes among infants with in utero exposure to the 3 regimens, using data from two U.S.-based cohort studies. HealthDay News — For HIV-infected ...
Aidsmap

Why has the uptake of lopinavir/ritonavir oral pellets for children been slow?

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...